FAP overexpression induce Epithelial-Mesenchymal Transition (EMT) in oral squamous cell carcinoma by down-regulating DPP9 gene

AbstractFAP acts as a tumor promoter via epithelial-mesenchymal transition (EMT) in human oral squamous cell carcinoma (OSCC). The present study was designed to investigate the interaction proteins with FAP and explore the precise mechanism of FAP promoting EMT in OSCC. IP-MS analysis confirmed that DPP9 was an interacting protein of FAP. DPP9 was down-regulated in OSCC tissue samples compared with MNT using immunohistochemistry and quantitative-PCR detection. Lower DPP9 was correlated with unfavorable overall survival of patients with OSCC. Repressing DPP9 accelerates the proliferation of OSCC cells in vitro and in vivo. Mechanistically, overexpression of FAP downregulate the expression of the DPP9 and the effect of FAP on OSCC proliferation, migration, invasion and EMT could be reversed by up-regulated DPP9. Our study suggests that FAP could induce EMT and promote carcinogenesis in oral squamous cell carcinoma by down-regulating DPP9 gene. That will hint different dimension on therapy for patients with OSCC.

Download Full-text

Aberrant Expression and Subcellular Localization of PER2 Promote the Progression of Oral Squamous Cell Carcinoma

BioMed Research International ◽

10.1155/2020/8587458 ◽

2020 ◽

Vol 2020 ◽

pp. 1-10

Author(s):

Fengyuan Guo ◽

Qingming Tang ◽

Guangjin Chen ◽

Jiwei Sun ◽

Junyi Zhu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Subcellular Localization ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Aberrant Expression ◽

Mesenchymal Transition

Oral squamous cell carcinoma, one of the most prevalent cancer types in the world, has been confirmed under the influence of a key circadian gene, PER2, whose role has been identified in the development of some other types of cancers. However, the mechanism through which PER2 regulates the progress of OSCC remains largely unknown. In this study, we showed that besides the abnormal expression and subcellular localization of PER2 observed in OSCC tissues and cells as expected, these anomalous changes also existed in the adjacent noncancerous tissues, which was a novel finding in our research. The phase of PER2 rhythmic expression pattern in OSCC cells was later than that in oral keratinocytes in the protein level. In addition, we demonstrated that PER2 played as a resistant factor in the development of OSCC by upregulating TP53 and inhibiting epithelial-mesenchymal transition in vitro and in vivo. Taken together, our results identified that the development of OSCC is closely associated with PER2, the aberrant expression and subcellular localization of which facilitates the malignant progress.

Download Full-text

Sodium Phenylbutyrate Inhibits Tumor Growth and the Epithelial–Mesenchymal Transition of Oral Squamous Cell Carcinoma In Vitro and In Vivo

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2017.2418 ◽

2018 ◽

Vol 33 (4) ◽

pp. 139-145 ◽

Cited By ~ 2

Author(s):

Kun Qian ◽

Laiyu Sun ◽

Guoqing Zhou ◽

Haixia Ge ◽

Yue Meng ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Tumor Growth ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition ◽

Sodium Phenylbutyrate

Download Full-text

CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis

Cell Death and Disease ◽

10.1038/s41419-020-02978-w ◽

2020 ◽

Vol 11 (9) ◽

Author(s):

Xiao Jiang ◽

Jingpeng Liu ◽

Simin Li ◽

Bo Jia ◽

Zhijie Huang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition ◽

In Vivo Experiments ◽

Oral Cancer Cells

Abstract Long non-coding RNAs (lncRNAs), which may be modulated by chemokines, are key regulators in many cancers including oral squamous cell carcinoma (OSCC). An understanding of lncRNAs involved in chemokine (CC motif) ligand 18 (CCL18)-induced OSCC promotion remains elusive. The present study using lncRNA sequencing found LINC00319 to be significantly upregulated in OSCC cells subjected to rCCL18 stimulation. Furthermore, LINC00319 knockdown was found to attenuate the carcinogenic function of CCL18 in OSCC, reducing OSCC proliferation, metastasis, epithelial-mesenchymal transition (EMT), and angiogenesis. LINC00319 was demonstrated to act as a ceRNA in OSCC, which directly responded to miR-199a-5p and rescued the repression of FZD4 by miR-199a-5p. Functionally, in vitro and in vivo experiments showed that LINC00319 promoted OSCC growth and metastasis via downregulating miR-199a-5p and upregulating FZD4. In vitro rescue assays demonstrated that miR-199a-5p inhibitor or FZD4 overexpression reversed the effects of LINC00319 silencing in OSCC. Importantly, the expression of miR-199a-5p and FZD4 were found to be mediated by CCL18, and miR-199a-5p mimics inhibited the CCL18-promoting effects in oral cancer cells. Taken together, these results evidenced a mechanism of CCL18 action in OSCC mediated through the LINC00319/miR-199a-5p/FZD4 signaling pathway, which may comprise a potential target for OSCC therapeutic development.

Download Full-text

Single cell migration in oral squamous cell carcinoma - possible evidence of epithelial-mesenchymal transition in vivo

Journal of Oral Pathology and Medicine ◽

10.1111/jop.12321 ◽

2015 ◽

Vol 44 (9) ◽

pp. 674-679 ◽

Cited By ~ 8

Author(s):

David H. Jensen ◽

Jesper Reibel ◽

Ian C. Mackenzie ◽

Erik Dabelsteen

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Migration ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Single Cell ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition

Download Full-text

Role of miR‐218‐GREM1 axis in epithelial‐mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data

Journal of Cellular and Molecular Medicine ◽

10.1111/jcmm.15972 ◽

2020 ◽

Vol 24 (23) ◽

pp. 13824-13836

Author(s):

Yanpeng Wang ◽

Yifeng Jiang ◽

Long Chen

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Microarray Data ◽

Epithelial Mesenchymal Transition ◽

Vitro Study ◽

Mesenchymal Transition

Download Full-text

Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma

Molecular Biology of the Cell ◽

10.1091/mbc.e14-04-0868 ◽

2015 ◽

Vol 26 (5) ◽

pp. 821-831 ◽

Cited By ~ 21

Author(s):

Juliano D. Paccez ◽

Kristal Duncan ◽

Akhona Vava ◽

Ricardo G. Correa ◽

Towia A. Libermann ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Glycogen Synthase ◽

Mesenchymal Transition ◽

Therapeutic Implications

Deregulation of Axl in esophageal squamous cell carcinoma (OSCC) with potential therapeutic implications is described for the first time. This paper also sheds light on the understanding of how Axl regulates OSCC development in vitro and in vivo. Axl expression leads to an Akt-dependent regulation of glycogen synthase kinase 3β activity and the nucluear factor kappaB (NF-κB) pathway, affecting the epithelial–mesenchymal transition.

Download Full-text

Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells

Scientific Reports ◽

10.1038/s41598-020-80060-3 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Yu-Lin Chen ◽

Yi-Chen Yen ◽

Chuan-Wei Jang ◽

Ssu-Han Wang ◽

Hsin-Ting Huang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Migration ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition ◽

Promising Therapeutic Approach ◽

Sphere Formation

AbstractEphrin type-A receptor 10 (EPHA10) has been implicated as a potential target for breast and prostate cancer therapy. However, its involvement in oral squamous cell carcinoma (OSCC) remains unclear. We demonstrated that EPHA10 supports in vivo tumor growth and lymphatic metastasis of OSCC cells. OSCC cell migration, epithelial mesenchymal transition (EMT), and sphere formation were found to be regulated by EPHA10, and EPHA10 was found to drive expression of some EMT- and stemness-associated transcription factors. Among EPHA10 ligands, exogenous ephrin A4 (EFNA4) induced the most OSCC cell migration and sphere formation, as well as up-regulation of SNAIL, NANOG, and OCT4. These effects were abolished by extracellular signal-regulated kinase (ERK) inhibition and NANOG knockdown. Also, EPHA10 was required for EFNA4-induced cell migration, sphere formation, and expression of NANOG and OCT4 mRNA. Our microarray dataset revealed that EFNA4 mRNA expression was associated with expression of NANOG and OCT4 mRNA, and OSCC patients showing high co-expression of EFNA4 with NANOG or OCT4 mRNA demonstrated poor recurrence-free survival rates. Targeting forward signaling of the EFNA4-EPHA10 axis may be a promising therapeutic approach for oral malignancies, and the combination of EFNA4 mRNA and downstream gene expression may be a useful prognostic biomarker for OSCC.

Download Full-text